{"id":"W2027176779","doi":"10.1038/bjc.2011.201","title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital","funders":"","keywords":"Folinic acid; Oxaliplatin; Medicine; Bevacizumab; Capecitabine; Internal medicine; FOLFOX; Colorectal cancer; Population; Placebo; Hazard ratio; Fluorouracil; Oncology; Neutropenia; Gastroenterology; Surgery; Chemotherapy; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01263767,0.001238476,0.003922404,0.002195299,0.0003267892,0.00300473,0.001315903,0.00113806,0.01204902],"category_scores_gemma":[0.02453183,0.0006987173,0.00670453,0.003085217,0.0003684565,0.001583857,0.001417076,0.002648795,0.001929113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001615524,"about_ca_system_score_gemma":0.002627996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002568337,"about_ca_topic_score_gemma":0.005294082,"domain_scores_codex":[0.9919734,0.003682674,0.001388954,0.0005756797,0.001898783,0.0004805081],"domain_scores_gemma":[0.9805577,0.007540696,0.007364144,0.0007498425,0.002743948,0.001043691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1167881,0.0007298752,0.007674604,0.08348391,0.0290276,0.0002198366,0.0002279684,0.001513877,0.002683219,0.001234129,0.06686598,0.6895508],"study_design_scores_gemma":[0.08573972,0.0376766,0.109087,0.05276265,0.132826,0.002005991,0.0003012136,0.0008375889,0.003682692,0.003446648,0.571193,0.0004409064],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04095284,0.889412,0.001925014,0.006926526,0.00475826,0.001336827,0.03311338,0.0001751864,0.02139992],"genre_scores_gemma":[0.3154329,0.5561017,0.006146017,0.02162877,0.009201923,0.002814914,0.07556511,0.0004974271,0.0126112],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01263767,"threshold_uncertainty_score":0.06683522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04379543442494756,"score_gpt":0.3317247483501661,"score_spread":0.2879293139252185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}